287 related articles for article (PubMed ID: 3859023)
1. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
[No Abstract] [Full Text] [Related]
2. [High-dose cytosine arabinoside and L-asparaginase in the treatment of refractory or recurrent acute non-lymphoblastic leukemia].
Sanz MA; Borrego D; Martín-Aragonés G; Martínez JA; Lorenzo I; Sanz G; Sayas MJ; Jarque I; Pastor E; Rafecas J
Sangre (Barc); 1987; 32(4):476-81. PubMed ID: 3660187
[No Abstract] [Full Text] [Related]
3. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
[TBL] [Abstract][Full Text] [Related]
4. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia].
Ohshima A; Yoshida K; Miyazaki S; Fukushima Y; Miura AB; Endo K; Ando H; Sasaki H; Saito S; Sato I
Gan To Kagaku Ryoho; 1989 Jan; 16(1):139-42. PubMed ID: 2643393
[No Abstract] [Full Text] [Related]
5. [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
Marín P; Grañena A; Carreras E; Sierra J; Olivé MT; Rozman C
Sangre (Barc); 1984; 29(4-A):399-404. PubMed ID: 6594782
[No Abstract] [Full Text] [Related]
6. Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
Capizzi RL; Powell BL; Cooper MR; Stuart JJ; Muss HB; Richards F; Jackson DV; White DR; Spurr CL; Zekan PJ
Semin Oncol; 1985 Jun; 12(2 Suppl 3):105-13. PubMed ID: 3892697
[No Abstract] [Full Text] [Related]
7. Sequential high-dose cytosine arabinoside and L-asparaginase in childhood leukemia in relapse.
Ettinger LJ; Biener R; Finklestein JZ; Kamalakar P; Jones GR; Avramis VI; Holcenberg JS
Semin Oncol; 1985 Jun; 12(2 Suppl 3):155-9. PubMed ID: 3859930
[No Abstract] [Full Text] [Related]
8. Intermediate dose methotrexate and sequential L-asparaginase for treatment of refractory acute lymphocytic leukaemia.
Shetty PA; Kurkure PA; Dasgupta A
Indian J Cancer; 1984; 21(1):45-9. PubMed ID: 6595214
[No Abstract] [Full Text] [Related]
9. Methotrexate followed by L-asparaginase for the treatment of acute non lymphoid leukemia.
Tribalto M; Amadori S; Avvisati G; Del Bianco P; Franchi A; Gallerano T; Papa G; Mandelli F
Haematologica; 1985; 70(4):319-23. PubMed ID: 3935530
[No Abstract] [Full Text] [Related]
10. [Complete remission obtained in refractory acute lymphocytic leukemia using high-dose cytosine arabinoside combined with low-dose L-asparaginase].
Inagaki C; Ito K; Omori I; Shimazaki C; Nishio A; Haruyama H; Isemura T; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Feb; 12(2):379-82. PubMed ID: 3855616
[TBL] [Abstract][Full Text] [Related]
11. [A case of refractory acute lymphocytic leukemia responded to an intermediate-dose of cytosine arabinoside (ID Ara-C) therapy].
Hirota Y; Shibuya T; Ohhara N; Okamura S; Iwagiri R; Tada Y; Otsuka T; Nagano M; Tsuda Y; Niho Y
Rinsho Ketsueki; 1986 Jun; 27(6):941-6. PubMed ID: 3463812
[No Abstract] [Full Text] [Related]
12. [Induction of cellular differentiation in the treatment of acute leukemias: preliminary report of the use of low doses of cytosine arabinoside for the induction of remission].
Marín-López A; Lobato-Mendizábal E; Munive-Ordóñez I; Ruiz-Argüelles GJ
Rev Invest Clin; 1984; 36(3):247-51. PubMed ID: 6515157
[No Abstract] [Full Text] [Related]
13. [High-dose treatment].
Takaku F
Gan To Kagaku Ryoho; 1985 Apr; 12(4):830-8. PubMed ID: 3872631
[TBL] [Abstract][Full Text] [Related]
14. Sequential high-dose cytosine arabinoside-asparaginase treatment in advanced childhood leukemia.
Wells RJ; Feusner J; Devney R; Woods WG; Provisor AJ; Cairo MS; Odom LF; Nachman J; Jones GR; Ettinger LJ
J Clin Oncol; 1985 Jul; 3(7):998-1004. PubMed ID: 3860629
[TBL] [Abstract][Full Text] [Related]
15. Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia.
Pratt CB; Roberts D; Shanks E; Warmath EL; Jackson R
Cancer Res; 1973 Sep; 33(9):2020-5. PubMed ID: 4516498
[No Abstract] [Full Text] [Related]
16. [Intensification of treatment of lymphoblastic leukemia in children].
Michalewska D; Radwańska U
Pediatr Pol; 1985 Jan; 60(1):5-13. PubMed ID: 3862059
[No Abstract] [Full Text] [Related]
17. Study of cytosine arabinoside (NSC-63878) synchronization plus vincristine (NSC-67574), prednisone (NSC-10023), and L-asparaginase (NSC-109229) for remission induction in advanced acute leukemia in children.
Sutow WW; Thomas D; Steuber CP; Pullen J; Vats T; Bryan JH; Morgan SK
Cancer Treat Rep; 1976 May; 60(5):591-4. PubMed ID: 991148
[TBL] [Abstract][Full Text] [Related]
18. Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia.
Gahrton G; Engstedt L; Franzén S; Gullbring B; Holm G; Höglund S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skarberg KO; Swedberg B; Udén AM
Cancer; 1974 Aug; 34(2):472-9. PubMed ID: 4527847
[No Abstract] [Full Text] [Related]
19. Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemia.
Amadori S; Tribalto M; Pacilli L; De Laurentis C; Papa G; Mandelli F
Cancer Treat Rep; 1980; 64(8-9):939-42. PubMed ID: 6934851
[TBL] [Abstract][Full Text] [Related]
20. Experience with intermediate- and high-dose cytosine arabinoside in relapsed and refractory acute leukaemia.
Willemze R; Fibbe WE; Zwaan FE
Neth J Med; 1983; 26(8):215-9. PubMed ID: 6580554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
